Episodic movement disorders: from phenotype to genotype and back.

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• Episodic dyskinetic movement disorders are rare and heterogeneous, often presenting with normal neurological findings between episodes.
• These disorders can also be a feature of complex chronic neurological conditions.

Purpose of the Study:

• To review recent genetic findings and clinical aspects of episodic dyskinesias.
• To highlight the role of molecular genetics in understanding the causes of these disorders.

Main Methods:

• Literature review focusing on recent advancements in molecular genetics and phenotyping.
• Analysis of identified gene mutations (PRRT2, ATP1A3) and their associated clinical presentations.

Main Results:

• Heterozygous mutations in the PRRT2 gene are linked to paroxysmal kinesigenic dyskinesia and benign familial infantile seizures.
• Heterozygous de novo mutations in the ATP1A3 gene cause alternating hemiplegia of childhood, a condition with episodic dyskinesia.
• The clinical spectrum associated with PRRT2 and ATP1A3 mutations is continually expanding.

Conclusions:

• Accurate phenotyping combined with advanced molecular genetics has significantly improved the understanding of episodic dyskinesia's genetic basis.
• Ongoing research into PRRT2 and ATP1A3 mutations continues to reveal new clinical insights into these rare neurological disorders.